Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Frederic Moll Insider Profile
4 Followers
Frederic Moll, Director at Intersect ENT, holds 809.61K shares in PROCEPT BioRobotics (Ticker: PRCT), holds 0.00 shares in Shockwave Medical (Ticker: SWAV), holds 260.96K shares in Intersect ENT (Ticker: XENT).
Profitable Transactions
6 out of 11 Profitable Transactions
Average Return
-24.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Frederic Moll holds in companies
Most Profitable Insider Trade
Stock:
Intersect ENT
(XENT)
(XENT)
Rating:Informative Buy
Date:Aug 07, 2014 - Aug 07, 2015
Return:+109.70%
The most profitable trade made by Frederic Moll
Frederic Moll's Trading History
Intersect ENT
Jun 08, 2020
―
Uninformative Buy
―
$7.37M
Venus Concept
Nov 07, 2019
Director
Uninformative Buy
―
$274.71K
Shockwave Medical
May 31, 2024
―
Uninformative Sell
―
$0.00
PROCEPT BioRobotics
Jun 06, 2024
Director
Uninformative Buy
―
$76.47M
BIOLASE
Jul 03, 2017
Director
Informative Buy
238.20K
$592.17
Hansen Medical
Mar 05, 2012
―
Informative Sell
109.97K
$11.08M
Mako Surgical
―
―
―
―
List of latest transactions for each holding click on a transaction to see Frederic Moll's performance on stock
You May Also Like
Frederic Moll insider profile FAQ
What is the percentage of profitable transactions made by Frederic Moll?
The percentage of profitable transactions made by Frederic Moll is 55%.
What is the average return per transaction made by Frederic Moll?
The average return per transaction made by Frederic Moll is -24.50%.
What stocks does Frederic Moll hold?
Frederic Moll holds: XENT, VERO, SWAV, PRCT, BIOLQ, HNSN, MAKO stocks.
What was Frederic Moll’s latest transaction?
Frederic Moll latest transaction was an Uninformative Buy of ―.
What was Frederic Moll's most profitable transaction?
Frederic Moll’s most profitable transaction was an Informative Buy of XENT stock on August 7, 2014. The return on the trade was 109.70%.
What is Frederic Moll's role in Intersect ENT?
Frederic Moll's role in Intersect ENT is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.